The Comparative Advantage of the Optrell Mapping Catheter in Ventricular Arrhythmias From the Papillary Muscles

Inclusion criteria

• Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements
• Patient is not cognitively impaired, pregnant, prisoner, employed by Northwell, uninsured, or a student
• Age 18-75 years old with the ability to consent for the procedure
• Patient is consented within the enrollment window of the therapy received, as applicable
• Patients with frequent (>10%) or symptomatic PVCs with ECG morphology consistent with papillary muscle origin.
• Papillary muscle PVCs in setting of cardiomyopathy.
• Patients prescribed by their treating physician to undergo the procedure with the Optrell™ mapping catheter as part of routine clinical care.
• Patient demonstrates proficiency in the English language; reading, writing, and conversational

Exclusion criteria

• Patient who is, or is expected to be, inaccessible for follow-up
• Participation is excluded by local law
• Patient is currently enrolled or plans to enroll in concurrent drug/device study that may confound the study results
• Unable to consent
• PVC from site other than papillary muscle
• Acute coronary syndrome
• Congestive heart failure in acute decompensation
• Rapid atrial fibrillation
• Requiring ventricular pacing